Código QR (código de barras bidimensional)

Dasatinib‐induced chylothorax: An unusual presentation of a common adverse event—A case report with literature review

Abstract Tyrosine kinase inhibitors (TKIs) are the key agents for treating CML and BCR–ABL+ B‐ALL. Dasatinib is a potent second‐generation TKI. Here, we have discussed the case of a 51‐year‐old gentleman diagnosed with B‐myeloid mixed‐phenotype acute leukemia with t(9;22)(q34.1;q11.2); BCR–ABL1p210,...

תיאור מלא

שמור ב:
Principais autores: Theresa Paul, Anil Yousaf Ellahie, Yazan Salah Almohtasib, Urshita Sinha, Halima El Omri
פורמט: Artigo
שפה:Inglês
יצא לאור: Wiley 2021-08-01
סדרה:eJHaem
נושאים:
chylothorax
Dasatinib
glucose–lipid metabolism
imatinib
leukemia
pleural effusion
גישה מקוונת:https://doi.org/10.1002/jha2.226
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים